Skip to main content

About UC San Diego Stroke Center


We are a worldwide leader in the development of novel therapeutics and diagnostics for stroke care. UC San Diego was the first to use intravenous tPA for stroke, a treatment developed in the laboratory of Dr. Justin Zivin at UC San Diego. Our research portfolio continues to expand, and we remain motivated to provide cutting-edge treatments for our patients. We invite you to explore everything our stroke center has to offer!

Research Projects

Current stroke research projects include novel thrombolytic and adjuvant therapies for acute ischemic stroke, anticoagulant use for embolic stroke of undetermined source based on cardiac biomarkers, understanding nuances of management of malignant strokes and intracranial hemorrhage, and development and implementation of a stroke advance directive. Residents and fellows learn state-of-the-art stroke care from leaders in the field and participate in the discovery and development of new treatments for cerebrovascular disease.

More about our Research

Education & Training

Our one-year vascular neurology fellowship was accredited by the ACGME in November 2006. Currently, a maximum of four fellows are accepted each year to the fellowship program. 

More about our fellowship